Increased vascular endothelial growth factor in patients with cyanotic congenital heart diseases may not be normalized after a Fontan type operation

Annals of Thoracic Surgery

Volumn 78, Issue 3, 2004, Pages 942-946

  Suda, Kenji ^a   Matsumura, Masahiko ^a   Miyanish, Setsuko ^b   Uehara, Kyokun ^a   Sugita, Takaaki ^a   Matsumoto, Masahiko ^a  

^a TENRI HOSPITAL   (Japan)

^b Tenri Institute of Medical Research   (Japan)

Author keywords

21

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYANOTIC HEART DISEASE; FONTAN PROCEDURE; HEMODYNAMICS; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VENOUS PRESSURE;

CHILD; CHILD, PRESCHOOL; CYANOSIS; ENDOTHELIAL GROWTH FACTORS; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; OXYGEN;

EID: 4444249600     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.03.039     Document Type: Article

References (15)

1. Moore J.W., Kirby W.C., Madden W.A., Gaither N.S. Development of pulmonary arteriovenous malformation after modified Fontan operations. J Thorac Cardiovasc Surg. 98:1989;1045-1050
2. Clapp S., Morrow W.R. Development of superior vena cava to pulmonary vein fistulae following modified Fontan operation case report of a rare anomaly and embolization therapy. Pediatr Cardiol. 19:1998;363-365
3. Heinemann M, Breuer J, Steger V, Steil E, Sieverding L, Ziemer G. Incidence and impact of systemic venous collaterals development after Glenn and Fontan procedures. Thorac Cardiovasc Surg 2001;491:72-8
4. Kaulitz R., Ziemer G., Paul T., Peuster M., Bertram H., Hausdorf G. Fontan-type procedures residual lesions and late interventions. Ann Thorac Surg. 74:2002;778-785
5. Starnes S.L., Duncan B.W., Kneebone J.M., Rosenthal G.L., Jones T.K., Grifka R.G., Cecchin F., Owens D.J., Fearneyhough C., Lupinetti F.M. Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg. 119:2000;534-539
6. Himeno W., Akagi T., Furui J., Maeno Y., Ishii M., Kosai K., Murohara T., Kato H. Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatr Cardiol. 24:2003;127-132
7. Starnes S.L., Duncan B.W., Kneebone J.M., Rosenthal G.L., Patterson K., Fraga C.H., Kilian K.M., Mathur S.K., Lupinetti F.M. Angiogenic proteins in the lungs of children after cavopulmonary anastomosis. J Thorac Cardiovasc Surg. 122:2001;518-523
8. Obermair A., Tempfer C., Hefler L., Preyer O., Kaider A., Zeillinger R., Leodolter S., Kainz C. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer. Br J Cancer. 77:1998;1870-1874
9. Ootaki Y., Yamaguchi M., Yoshimura N., Oka S., Yoshida M., Hasegawa T. Vascular endothelial growth factor in children with congenital heart disease. Ann Thorac Surg. 75:2003;1523-1526
10. Suzuma I., Hata Y., Clermont A., Pokras F., Rook S.L., Suzuma K., Feener E.P., Aiello L.P. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes. 50:2001;444-454
11. Hollingsworth S.J., Tang C.B., Dialynas M., Barker S.G. Varicose veins loss of release of vascular endothelial growth factor and reduced plasma nitric oxide. Eur J Vasc Endovasc Surg. 22:2001;551-556
12. Weber H.S. Incidence and predictors for the development of significant supradiaphragmatic decompressing venous collateral channels following creation of Fontan physiology. Cardiol Young. 11:2001;289-294
13. Dirix L.Y., Vermeulen P.B., Pawinski A., et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer. 76:(2):1997;238-243
14. Shimada H., Takeda A., Nabeya Y., et al. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. Cancer. 92:2001;663-669
15. Coskun U., Gunel N., Sancak B., et al. Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients. Breast. 12:2003;104-110